Portland, OR, Sept. 30, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global autism spectrum disorders market generated $27.3 billion in 2021, and is estimated to reach $43.2 billion by 2031, witnessing a CAGR of 4.6% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/13707
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $27.3 Billion |
| Market Size in 2031 | $43.2 Billion |
| CAGR | 4.6% |
| No. of Pages in Report | 300 |
| Segments covered | Disease, Service, Location, and Region |
| Drivers | Increase in the prevalence of autism spectrum disorder (ASD) |
| Rise in the diagnosis rate of autism spectrum disorder (ASD) | |
| Increase in R&D activity for advancements in autism spectrum disorder treatment | |
| Latest product launch and product approvals | |
| Opportunities | Increase in advancements in biotechnology |
| Rise in government initiatives to provide advanced healthcare facilities and financial support | |
| Increase in access to healthcare facilities globally | |
| Surge in healthcare expenditure | |
| Restraints | High cost associated with the autism spectrum disorder treatment |
Covid-19 Scenario:
- The outbreak of the COVID-19 pandemic had a negative impact on the global autism spectrum disorders market, owing to the implementation of lockdown in many countries and disrupted supply chain.
- The entire healthcare industry was focused on emergency health services related to the Covid-19 disease. Most other health issues of patients were given less priority.
- However, the autism spectrum disorders market is anticipated to grow steadily in the post pandemic period.
The report offers a detailed segmentation of the global autism spectrum disorders market based on disease, service, location, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.
Based on disease, the autistic disorder segment held the largest share in 2021, contributing to nearly half of the global autism spectrum disorders market, and is likely to maintain its leadership status during the forecast period. The Asperger syndrome segment, nevertheless, is expected to manifest the highest CAGR of 5.4% from 2022 to 2031. The research also analyzes the segments such as pervasive development disorder (PDD) and others.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/13707
In terms of service, the behavioural approaches segment held the largest share in 2021, accounting for nearly three-fifths of the global autism spectrum disorders market, and would rule the roost through 2031. However, the medication segment is estimated to witness the fastest CAGR of 6.0% during the forecast period. The study also encompasses the segments such as early intervention, medication and other services.
Based on location, the education counsellor center segment was largest market in 2021, accounting for nearly three-fifths of the global autism spectrum disorders market, and is likely to maintain its leadership status during the forecast period. The hospitals segment, on the other hand, is expected to manifest the highest CAGR of 5.7% during the forecast period.
Based on region, North America accounted for the largest share in 2021, contributing to nearly three-fifths of the global autism spectrum disorders market, and is likely to dominate the market during the forecasted timeframe. However, Asia-Pacific is projected to exhibit the fastest CAGR of 5.5% during the forecast period. The research also analyzes the regions including Europe and LAMEA.
Leading players of the global autism spectrum disorders market analyzed in the research include Abbvie Inc, Axial therapeutics, Bristol Myers Squibb Co., Cognoa Inc, Curemark LLC, dfusion inc.,EarliTec Diagnostics Inc, Jazz Pharmaceuticals, Johnson & Johnson, and Novartis AG.
The report analyzes these key players of the global autism spectrum disorders market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Official Press Release- https://www.alliedmarketresearch.com/press-release/autism-spectrum-disorders-market.html
Trending Reports in Healthcare Industry-
Syphilis Testing Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Capsule Endoscopy System Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Micromanipulators Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Flow Cytometry Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Extremity Reconstruction Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
